Definitive Contract 75N93023C00037

Award Date 9/1/23
Potential Completion Date 8/31/25
Potential Value $600K
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Charlottesville, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The contract, valued at $1,499,998.00, is for the development of innovative pediatric oral formulations for second-line tuberculosis drugs. This contract is set aside for small businesses. Luna Labs USA LLC, a leading provider of advanced...
This is a $299,998.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a for-profit manufacturer of goods. The contract is for a firm fixed price and does not have a set-aside designation. Based on Luna Innovations' background, the contract likely involves the provision of specialized optical and sensing instruments, fiber optic technologies, and...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated, a leading provider of advanced fiber optic sensing and measurement systems. The contract, valued at $224,997, is for the development of "INNOVATIVE ORAL FORMULATIONS FOR ANTI-TB DRUGS." This Firm Fixed Price contract has an ultimate completion date of August 25, 2017. Luna Innovations, a for-profit manufacturer, is...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...
This is a $249,996.84 Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Luna Labs USA LLC, a small business manufacturing firm based in Charlottesville, Virginia. The contract is for a project titled "Layer-by-Layer Sustained Delivery for HIV-1 Vaccine", focused on medical research and development. This SBIR Phase I award supports early-stage research and development activities. Luna Labs USA LLC is a division of Luna Innovations...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Luna Labs USA LLC, a small business prime contractor, for the AMPFLI: Rapid Nucleic Acid Test for HIV-1 under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a period of performance ending on July 31, 2025. The contract involves the development of a rapid nucleic acid test for HIV-1. Luna Labs USA LLC, a division of...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,997.00 Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated for the development of a "Ligand Magneto Kit for Fast Modular Bacteria Collection." This definitive, firm fixed-price contract will be performed in Danville, Virginia and is scheduled for completion by July 31, 2016. Luna Innovations is a leading provider...
This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Luna Innovations Incorporated. The objective of this $299,956 Firm Fixed Price contract is to develop a novel layer-by-layer (LBL) RNA vaccine that can provide long-lasting protection against HIV. Luna Innovations is a small business that specializes in fiber optic sensing and measurement systems, and has previously...

This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The $599,993.00 award falls under the Small Business Innovation Research (SBIR) program and is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models." Luna Labs USA LLC is a small business known for its expertise in advanced materials, sensors, and biomedical research and development. This contract award supports NIAID's mission to conduct and support research to understand, treat, and prevent infectious, immunologic, and allergic diseases. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the period of performance runs through August 31, 2025.

Generated 5/1/24, 10:28 AM